| D-0676-2025 | Class II | Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, | September 5, 2025 |
| D-0677-2025 | Class II | Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex In | September 5, 2025 |
| D-0496-2025 | Class II | Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, 15 mL, Rx Only, Sterile, Manufa | May 28, 2025 |
| D-0494-2025 | Class II | Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toro | May 28, 2025 |
| D-0457-2025 | Class II | Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ont | May 28, 2025 |
| D-0495-2025 | Class II | Azelastine HCl Ophthalmic Solution, USP, 0.05%, 6 mL, Rx Only, Sterile, Mfg. by: Apotex Inc., Toront | May 28, 2025 |
| D-0326-2024 | Class II | Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill, Rx Only, Manufac | February 9, 2024 |
| D-0119-2024 | Class II | Paroxetine Hydrochloride Tablets USP, RX only, 10 mg a) 30-count bottle, NDC#: 60505-0097-1; b) 10 | November 1, 2023 |
| D-0120-2024 | Class II | Paroxetine Hydrochloride Tablets USP, RX only, 20 mg, a) 100-count bottle, NDC#:60505-0083-2; b) 10 | November 1, 2023 |
| D-0122-2024 | Class II | Paroxetine Hydrochloride Tablets USP, RX only, 40 mg, 1000-count bottle, NDC#:60505-0101-4 Manufactu | November 1, 2023 |
| D-0121-2024 | Class II | Paroxetine Hydrochloride Tablets USP, RX only, 30 mg, a)30-count bottle, NDC#: 60505-0084-1, b)100-c | November 1, 2023 |
| D-0568-2023 | Class II | Calcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 200 USP Calci | April 26, 2023 |
| D-0433-2023 | Class II | Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper bottle, NDC 60 | March 1, 2023 |
| D-0093-2023 | Class III | Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario | December 21, 2022 |
| D-1285-2022 | Class II | Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 2 | July 7, 2022 |
| D-0881-2022 | Class III | Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontar | May 3, 2022 |
| D-0324-2021 | Class II | Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. To | March 31, 2021 |
| D-0262-2021 | Class I | Enoxaparin Sodium Injection, USP 120 mg/ 0.8 mL Single Dose Syringes with Automatic Safety Device Fo | February 2, 2021 |
| D-0261-2021 | Class I | Enoxaparin Sodium Injection, USP 100 mg/mL Single Dose Syringes with Automatic Safety Device For Sub | February 2, 2021 |
| D-0106-2021 | Class II | Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle, NDC 60505-2675-8; b) 30 c | November 11, 2020 |